Ergoset oral bromocriptine D2 dopamine agonist: ERGO began enrollment in a double-blind U.S. Phase II/III trial in 400 obese patients. Patients will receive pla

The trial is intended to determine the best dose of Ergoset to use

Read the full 137 word article

How to gain access

Continue reading with a
two-week free trial.